Line 12: |
Line 12: |
| |Banumathy Gowrishankar || PhD || Cancer Genetics, Inc || Rutherford, NJ USA | | |Banumathy Gowrishankar || PhD || Cancer Genetics, Inc || Rutherford, NJ USA |
| |- | | |- |
− | |Christine Bryke || MD || Beth Israel Deaconess Medical Center, CGC Myeloid workgroup || Boston, MA USA | + | |Christine Bryke || MD || Beth Israel Deaconess Medical Center; CGC Myeloid workgroup || Boston, MA USA |
| |- | | |- |
− | |Fabiola Quintero-Rivera || MD PhD || University of California, CGC Myeloid workgroup || Los Angeles, CA | + | |Fabiola Quintero-Rivera || MD PhD || University of California; CGC Myeloid workgroup || Los Angeles, CA |
| |- | | |- |
− | |Fei Yang || MD MS || Oregon Health & Science University, CCGA Workgroup || Portland, OR USA | + | |Fei Yang || MD MS || Oregon Health & Science University; CCGA Workgroup || Portland, OR USA |
| |- | | |- |
| |Gordana Raca || PhD || University of Chicago || Chicago, IL USA | | |Gordana Raca || PhD || University of Chicago || Chicago, IL USA |
Line 22: |
Line 22: |
| |H Chen || Qualification || CCGA Workgroup || Location | | |H Chen || Qualification || CCGA Workgroup || Location |
| |- | | |- |
− | |Jane Houldsworth || PhD || Cancer Genetics, Inc, Renal Cell Carcinoma workgroup || Franklin Lakes, NJ USA | + | |Jane Houldsworth || PhD || Cancer Genetics, Inc; Renal Cell Carcinoma workgroup || Franklin Lakes, NJ USA |
| |- | | |- |
| |Jennelle Hodges || PhD FACMG || Cedars-Sinai Medical Center, new BOD member, member of CGC Myeloid workgroup || Los Angeles, CA USA | | |Jennelle Hodges || PhD FACMG || Cedars-Sinai Medical Center, new BOD member, member of CGC Myeloid workgroup || Los Angeles, CA USA |
Line 36: |
Line 36: |
| |Patty Greipp || DO || Mayo Clinic || Rochester, MN USA | | |Patty Greipp || DO || Mayo Clinic || Rochester, MN USA |
| |- | | |- |
− | |Emmadi Rajyasree || MD || University of Illinois at Chicago, Renal Cell Carcinoma workgroup || Chicago IL, USA | + | |Emmadi Rajyasree || MD || University of Illinois at Chicago, Renal Cell Carcinoma workgroup || Chicago, IL USA |
| |- | | |- |
| |Rashmi Kanagal || MD || CGC Myeloid workgroup || Anderson Cancer Center | | |Rashmi Kanagal || MD || CGC Myeloid workgroup || Anderson Cancer Center |
| |- | | |- |
− | |Sally Jeffries || Qualification || Affiliation || Location | + | |Sally Jeffries || Qualification || CGC Myeloid workgroup || Birmingham, England |
| |- | | |- |
− | |S Shetty || Qualification || Affiliation || Location | + | |S Shetty || Qualification || CGC Myeloid workgroup; Case Western Reserve University || Cleveland, OH USA |
| |- | | |- |
| |SL Harris || BA || SUNY Plattsburgh || Plattsburgh NY USA | | |SL Harris || BA || SUNY Plattsburgh || Plattsburgh NY USA |
Line 52: |
Line 52: |
| |Xinjie Xu || PhD FACMG || University of Utah || Salt Lake City, UT USA | | |Xinjie Xu || PhD FACMG || University of Utah || Salt Lake City, UT USA |
| |- | | |- |
− | |Yajuan Liu || PhD || University of Washington || Seattle, WA | + | |Yajuan Liu || PhD || University of Washington; Renal cell Carcinoma workgroup || Seattle, WA |
| |- | | |- |
| | Scott Newman || PhD || St Jude Children's Research Hospital || Memphis, TN USA | | | Scott Newman || PhD || St Jude Children's Research Hospital || Memphis, TN USA |